Marta Gazzotti
YOU?
Author Swipe
View article: Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry Open
Aims The availability of novel lipid-lowering therapies (LLTs) has remarkably changed the clinical management of homozygous familial hypercholesterolaemia (HoFH). The impact of these advances was evaluated in a cohort of 139 HoFH patients …
View article: Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study Open
View article: Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group Open
Detection and treatment of patients with familial hypercholesterolemia (FH) starting from childhood is fundamental to reduce morbidity and mortality. The activity of National realities such as the LIPIGEN (LIpid transPort disorders Italian…
View article: FGF-5 uniquely identifies subjects with heterozygous familial hypercholesterolemia: Results from a proteomics study
FGF-5 uniquely identifies subjects with heterozygous familial hypercholesterolemia: Results from a proteomics study Open
View article: Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia?
Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia? Open
View article: Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia Open
Background Evidence suggests that LPA risk genotypes are a possible contributor to the clinical diagnosis of familial hypercholesterolemia (FH). This study aimed at determining the prevalence of LPA risk variants in adult individuals with …
View article: Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group
Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group Open
[This corrects the article DOI: 10.3389/fgene.2022.912510.].
View article: Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network Open
View article: Immune-inflammatory proteomics associated with elevated cardiovascular risk in genetically determined Familial Hypercholesterolemia
Immune-inflammatory proteomics associated with elevated cardiovascular risk in genetically determined Familial Hypercholesterolemia Open
View article: The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group Open
Pathology registers can be a useful tool to overcome obstacles in the identification and management of familial hypercholesterolemia since childhood. In 2018, the LIPIGEN pediatric group was constituted within the Italian LIPIGEN study to …
View article: Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study Open
View article: Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN)
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) Open
Dear Editor, Familial hypercholesterolemia (FH) is a common genetic disease due to mutations causing lifelong exposure to elevated low-density lipoprotein cholesterol (LDL-C) levels, a causal factor for premature occurrence of atherosclero…
View article: Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies
Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies Open
Aims As the potential impact of statins on cognitive decline and dementia is still debated, we conducted a meta-analysis of observational studies to examine the effect of statin use on the risk of Alzheimer’s disease (AD) and dementia. Met…
View article: How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia Open
View article: Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study Open
Aim Statin‐associated muscle symptoms (SAMS) are a major determinant of poor treatment adherence and/or discontinuation, but a definitive diagnosis of SAMS is challenging. The PROSISA study was an observational retrospective study aimed to…
View article: Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials Open